Recent News

By Category: Research

Plague researchers race to beat bioterrorists

(Trudeau Institute) Given the many pressing concerns of the day, fear of plague probably isn’t what causes most Americans to lose sleep. But for those whose responsibility it is to combat bioterrorism, plague is among the highest priorities.

September 20, 2010
| Filed under Research
Share

Firm Wins Contract for Work on Modified Anthrax Vaccine

Maryland biopharmaceutical firm Emergent BioSolutions last week announced it had received a federal contract valued as high as $28.7 million to conduct further work on a modified version of its anthrax vaccine, the Center for Infectious Disease Research and Policy reported (see GSN, July 14). The “third-generation” vaccine would incorporate BioThrax, now the only anthrax Read More »

September 8, 2010
| Filed under Countermeasures and Research
Share

BARDA funds drug development for biothreats, antibiotic resistance

The U.S. Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA) today awarded a contract to develop an antibiotic that could be used against possible two types of bioterrorism as well as common infections that are becoming resistant to antibiotics.

August 30, 2010
| Filed under Research
Share

Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys.

Related Articles Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys. Vaccine. 2010 Aug 19; Authors: Zielinski RJ, Smedley JV, Perera PY, Silvera PM, Waldmann TA, Capala J, Perera LP Despite the eradication of smallpox, there is Read More »

August 27, 2010
| Filed under Research
Share

Progress toward development of vaccines against melioidosis: A review.

Related Articles Progress toward development of vaccines against melioidosis: A review. Clin Ther. 2010 Aug;32(8):1437-1445 Authors: Sarkar-Tyson M, Titball RW Background: Melioidosis is a serious and often fatal disease that is prevalent in subtropical and tropical climates, primarily in at-risk groups (eg, those with diabetes, alcoholism, or other cause of immunosuppression). Treatment is often unsuccessful, Read More »